<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A platelet survival study with <z:chebi fb="1" ids="30430">indium</z:chebi>-111 oxine was performed in 6 patients with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A markedly shortened platelet life-span (range 0.50-2.65 days; <z:mpath ids='MPATH_458'>normal</z:mpath> 6.5-12 days) was obtained in each case </plain></SENT>
<SENT sid="2" pm="."><plain>Platelet production ranged from 53,100 to 430,800 platelets/mm3/day (<z:mpath ids='MPATH_458'>normal</z:mpath> 66,200 +/- 14,600) </plain></SENT>
<SENT sid="3" pm="."><plain>A second isotopic study was performed in 1 case with platelets from a <z:mpath ids='MPATH_458'>normal</z:mpath> compatible donor </plain></SENT>
<SENT sid="4" pm="."><plain>The nearly complete normalisation of the platelet life-span (from 0.85 to 5.50 days) indicates an intracorpuscular origin of the defect </plain></SENT>
</text></document>